88. Poster number I-15, P53 mutataion status differentially regulates autophagy under the Fbxl17-PRMT1 signaling cascade in colorectal cancer
So Hyun KWON (2025-05-23) (poster), FAOBMB 2025 (BEXCO BUSAN)
87. Poster number I-16, Epigenetic Silencing of GLS2 in the Tumor Core Drives Colorectal Cancer Survival and Metastasis Under Glutamine Deprivation (Best Poster Award)
Ji-Yeon LEE (2025-05-23) (poster), FAOBMB 2025 (BEXCO BUSAN)
86. Poster number G-19, Dysregulation of PHF6-LEO1 axis promotes colorectal cancer proliferation to metastasis (Best Poster Award)
Su Chan Park (2025-05-22) (poster), FAOBMB 2025 (BEXCO BUSAN)
85. Poster number D-108, Mechanisms of mucin hypersecretion and tumor progression in pseudomyxoma peritonei: insights from patient-derived organoid models
Taehan Yoon (2025-05-21) (poster), FAOBMB 2025 (BEXCO BUSAN)
84. Poster number #4106, Glutamine deficiency drives epigenetic silencing of GLS2 to promote survival and metastasis from the core region of colorectal cancer https://doi.org/10.1158/1538-7445.AM2025-4106
Ji-Yeon Lee (2025-04) (poster), 2025 AACR (American Association for Cancer Research) (Chicago, IL)
83. Poster number #184, PHF6-LEO1 axis depletion drives aggressive colorectal cancer through WNT activation and metabolic reprogramming with therapeutic implications https://doi.org/10.1158/1538-7445.AM2025-184
Su Chan Park (2025-04) (poster), 2025 AACR (American Association for Cancer Research) (Chicago, IL)
82. Poster number #B011, Harnessing epigenetic and metabolic biomarkers for targeted immunotherapy in colorectal cancer: Advances in precision medicine for solid tumors
Ji Min Lee (2025-03) (poster), AACR Special Conference on Functional and Genomic Precision Medicine in Cancer: Different Perspectives, Common Goals (Boston, MA)
81. The timing of surgical tumor resection affects survival outcomes in patients with glioblastoma
Sanghyeok Park (2025-01) (speaker), GIST-IBS-AMC Sleep Medicine Symposium, 2nd GIA Sleeposium (Daejeon, Korea)
80. Reprogramming the TME by Designing a Histone Modulator to Enhance Immune Cell Infiltration (Best Poster Award)
Il-Geun Park (2025-01) (poster), KSMCB 2025 Winter Conference (Yongpyong, Korea)
79. Nutrient-Dependent Regulation of Stemness in Breast Cancer by regulating ERRα
Jihyun Shin (2025-01) (poster), KSMCB 2025 Winter Conference (Yongpyong, Korea)
78. Reinvigorating Exhausted T Cell and Modulating Cancer-Associated Fibroblast from Patients in TME (International Invited Talk)
Ji Min Lee (2024-11) (speaker), PEGS Europe 2024 (Barcelona, Spain)
77. Reprogramming epigenetic crosstalk and genome modification in cancer
Ji Min Lee (2024-11) (speaker), The 19th Annual Meeting of The Korean Society of Gene and Cell Therapy (Seoul, Korea)
76. CD96 correlates with leukemic stem cell-mediated pro-tumorigenic activities and inhibitory immune regulation in acute myeloid leukemia
Yonghun Go (2024-10) (poster), Cytokines 2024 & KAI 2024 (Seoul, Korea)
75. Nutrient-Dependent Regulation of Immune Response in Breast Cancer by Regulating ERRα
Jihyun Shin (2024-10) (poster), Cytokines 2024 & KAI 2024 (Seoul, Korea)
74. Reprogramming the TME by Designing a Histone Modulator to Enhance Immune Cell Infiltration
Il-Geun Park (2024-10) (poster), Cytokines 2024 & KAI 2024 (Seoul, Korea)
73. Reprogramming TME by designed affinity-controlled epigenetic reader at chromatin marks
Ji Min Lee (2024-10) (speaker), KSMCB International Conference 2024(Jeju-island, Korea)
72. Controlling targeted protein degradation by posttranslational modifications in cancer
Ji Min Lee (2024-07) (speaker), KSBMB Drug Development Consortium 2024 (Jeju-island, Korea)
71. Reprogramming epigenetic crosstalk and genome modification in cancer
Ji Min Lee (2024-06) (speaker), KSMCB Cell Cycle Symposium 2024 (Siheung, Korea)
70. Chromatin Remodeling from Glutamine Deficiency in Cancer Core: GLS2 Impact on Colon Cancer Metastasis
Ji-Yeon Lee, Ji Min Lee (2024-05) (poster), KSBMB International Conference 2024 (Busan, Korea)
69. CD96 correlates with leukemic stem cell-mediated stemness and chemoresistance in acute myeloid leukemia
Yonghun Go, Ji Min Lee (2024-05) (poster), KSBMB International Conference 2024 (Busan, Korea)
68. Targeting PRRX1 in Cancer-Associated Fibroblasts: A Novel Approach to Inhibit Colorectal Cancer Progression
Sang-ah Park, Ji Min Lee (2024-05) (poster), KSBMB International Conference 2024 (Busan, Korea)
67. Reprogramming the TME by Designing a Histone Modulator to Enhance Immune Cell Infiltration
Il-Geun Park, Ji Min Lee (2024-05) (poster), KSBMB International Conference 2024 (Busan, Korea)
66. Unraveling the Connection Between Epigenetic Regulation of Glucose and Lipid Metabolism via LEO1 and SETD1A in Colon Cancers
Su Chan Park, Ji Min Lee (2024-05) (poster), KSBMB International Conference 2024 (Busan, Korea)
65. 세포 내 단백질의 Degron 조절은 세포막 수용체의 항체의약품 저항성을 개선할 수 있을까? Samsung Science & Technology Center (samsung-gtc.technology)
Ji Min Lee (2024-02) (speaker), Samsung GTC Bio 2024 (Busan, Korea)
64. Reprogramming epigenetic crosstalk and genome modification in cancer
Ji Min Lee (2023-12) (speaker), KSIB 2023 (Yeosu, Korea)
63. Reprogramming tumor microenvironment by designed affinity improved epigenetic reader at chromatin marks (International Invited Talk)
Ji Min Lee (2023-11) (speaker), Epicypher 2023 (Cancun, Mexico)
62. Glutamine-Independent Survival Mechanisms in Colorectal Cancer Cells: An Integrative RNA-seq, ATAC-seq, and miRNA-seq Study
Ji-Yeon Lee, Ji Min Lee (2023-11) (poster), 2023 Annual Conference of Korean Society for Bioinformatics (Yeosu, Korea)
61. ROS inhibits tumor suppressor degradation by decreasing the activities of PRMT5 in liver cancer
Hyuntae Im, Ji Min Lee (2023-11) (poster), KSMCB International Conference 2023 (Jeju, Korea)
60. Chromatin Epi-glue: Targeting Novel Chromatin Dynamics for Breast Cancer Therapy
Il-Geun Park, Sang-ah Park, Ji Min Lee (2023-11) (poster), KSMCB International Conference 2023 (Jeju, Korea)
59. Control of UCHL3-mediated Deubiquitination in the Crosstalk between Cancer and Cancer-associated Fibroblasts
Sang-ah Park (2023-09) (speaker), KAI-X Medical Science Symposium - Frontiers in Precision Medicine - University of Copenhagen-KAIST (Daejeon, Korea)
58. Functional Confirmation and Transcriptome Analysis of PHF6 as a Tumor Suppressor in Colon cancer (CONNECT Award & Program Directors Award)
Su Chan Park (2023-08) (speaker), Samsung Global Technology Symposium Conference 2023 (Seoul, Korea)
57. ‘Chromatin epi-glue’ Technology for Cell Therapy in Breast Cancer
Il-Geun Park (2023-06) (poster), Samsung Global Technology Symposium Conference 2023 (Seoul, Korea)
56. Noncoding RNA-inducible disease specific genome editing
Ji Min Lee (2023-06) (speaker), SSRC-K4DN (Korea 4D Nucleom club) Conference 2023 (Busan, Korea)
55. Digital Degron: A Potential Therapeutic Strategy of Breast Cancer Treatment via Autophagy Regulation (Young Scientist Award)
Il-Geun Park (2023-06) (speaker), SSRC-K4DN (Korea 4D Nucleom club) Conference 2023 (Busan, Korea)
54. Unveiling the Mechanism of Cancer Cell's Survival in Glutamine Deprivation: Exploring the Interplay between GLS2 and miR-21 in Metabolic and Epigenetic Regulation
Ji-Yeon Lee, Ji Min Lee (2023-06) (poster), SSRC-K4DN (Korea 4D Nucleom club) Conference 2023 (Busan, Korea)
53. Digital Degron: A Potential Therapeutic Strategy for Breast Cancer Treatment via Autophagy Induction
Il-Geun Park, Ji Min Lee (2023-05) (poster), KSBMB International Conference 2023 (Busan, Korea)
52. Functional Confirmation and Transcriptome Analysis of PHF6 as a Tumor Suppressor in Colon cancer
Su Chan Park, Ji Min Lee (2023-05) (poster), KSBMB International Conference 2023 (Busan, Korea)
51. The Role of PHF7 in Tumorigenesis of Glioblastoma Multiforme
Sanghyeok Park, Chang Rok Kim, Ji Min Lee (2023-05) (poster), KSBMB International Conference 2023 (Busan, Korea)
50. ROS inhibits tumor suppressor degradation by decreasing the activities of PRMT5 in liver cancer
Hyuntae Im, Ji Min Lee (2023-05) (poster), KSBMB International Conference 2023 (Busan, Korea)
49. Stemness of Gastric Cancer Stem-like Cells under Glucose Deprivation are Regulated via c-FOS/UCH-L3/β-catenin Axis
Sang-ah Park, Jae Hyeong Lee, Ji Min Lee (2023-05) (poster), KSBMB International Conference 2023 (Busan, Korea)
48. Unveiling the Mechanism of Cancer Cells’ Survival in Glutamine Deprivation: Exploring the Interplay between GLS2 and miR-21 in Metabolic and Epigenetic Regulation
Ji-Yeon Lee, Ji Min Lee (2023-05) (poster), KSBMB International Conference 2023 (Busan, Korea)
47. Poster number #3777, Section 11 Non-coding RNA in cancers and new techniques/technologies (9)
Ji Min Lee (2023-04) (poster), 2023 AACR (American Association for Cancer Research) (Orlando, Florida)
46. Poster number #1493, Section 12 Gene Regulation in Solid Tumors (20)
Ji Min Lee (2023-04) (poster), 2023 AACR (American Association for Cancer Research) (Orlando, Florida)
45. Cytosolic miRNA-Inducible Nuclear Translocation of CRISPR Protein for Disease-Specific Genome Modification (International Invited Talk)
Ji Min Lee (2023-01) (speaker), PEPTALK 2023 (San Diego, USA)
44. Reprogramming epigenetic crosstalk and genome modification in disease
Ji Min Lee (2023-01) (speaker), 2023 KSBMB Winter Workshop (Hongcheon, Korea)
43. Controlling epigenetic crosstalk and genome modification in cancer
Ji Min Lee (2022-12) (speaker), Epigenomics Symposium 2022 KSMCB (Hongcheon, Korea)
42. Reprogramming epigenetic crosstalk and genome modification in disease (International Invited Talk)
Ji Min Lee (2022-12) (speaker), The 45th Annual Meeting of the Molecular Biology Society of Japan (Chiba, Japan)
41. Controlling nuclear translocation of drug machinery by epigenetic engineering
Ji Min Lee (2022-11) (speaker), The Korean Society of Pharmacology (74th Autumn Annual Conference) (Gwangju, Korea)
40. Reprogramming epigenetic crosstalk and genome modification in disease
Ji Min Lee (2022-10) (speaker), KAIST-Kumamoto Joint Symposium (Kumamoto, Japan)
39. Autophagy Suppresses the Cancer Progression via Methyl-dependent Phospho-degron of ERRα
Il-Geun Park, Ji Min Lee (2022-09) (poster), International Conference of the Korean Society for Molecular and Cellular Biology 2022 (Jeju-island, Korea)
38. p53 status of colorectal cancer differentially regulates autophagy through the p53-Fbxl17-PRMT1 axis
Su Chan Park, Ji Min Lee (2022-09) (poster), International Conference of the Korean Society for Molecular and Cellular Biology 2022
37. UCH-L3 is required for β-catenin stabilization and increasing of stemness properties in GCSCs under stress conditions (Excellent Poster Award)
Jae Hyeong Lee, Jung-Shin Lee, Ji Min Lee (2022-09) (poster), International Conference of the Korean Society for Molecular and Cellular Biology 2022
36. Regulating Glucose and Glutamine Metabolism to Overcome Cisplatin Resistance in Intrahepatic Cholangiocarcinoma
So Mi Yang, Jung-Shin Lee, Ji Min Lee (2022-09) (poster), International Conference of the Korean Society for Molecular and Cellular Biology 2022
35. The role of GLS and micro-RNA 21 in cancer surviving in glutamine deprivation condition
Ji-Yeon Lee, Ji Min Lee (2022-09) (poster), International Conference of the Korean Society for Molecular and Cellular Biology 2022
34. The Role of PHF7 in Tumorigenesis of Glioblastoma Multiforme
Sanghyeok Park, Chang Rok Kim, Ji Min Lee (2022-09) (poster), International Conference of the Korean Society for Molecular and Cellular Biology 2022
33. Controlling nuclear translocation of drug machinery by epigenetic engineering
Ji Min Lee (2022-07) (speaker), KAIST-Kumamoto Joint Symposium for future medicine (On-line)
32. Reprogramming epigenetic crosstalk and genome modification in disease
Ji Min Lee (2022-06) (speaker), KMPC 2022 workshop (Jeju-island, Korea)
31. Programmed mRNA decay machinery for controlling disease-specific protein translocation
Ji Min Lee (2022-06) (speaker), KSMCB 2022 RNA Summer Symposium (Busan, Korea)
30. Controlling epigenetic crosstalk in stem cell differentiation and therapeutic application
Ji Min Lee (2021-11) (speaker), International Conference of the Korean Society for Molecular and Cellular Biology 2021 (Jeju-island, Korea)
29. Epigenetic reprogramming in stem cell differentiation and therapeutic application
Ji Min Lee (2021-10) (speaker), International Conference of the Genetics Society of Korea (ICGSK) 2021 (Siheung, Korea)
28. Controlling epigenetic crosstalk in trophectoderm differentiation and therapeutic application
Ji Min Lee (2021-01) (speaker), KSSCR 2021 Winter Conference (On-line)
27. RORalpha Regulates Cholesterol Metabolism of CD8+ T Cells for Articancer Immunity
Hyerin Song, Ji Min Lee (2021-01) (poster), International Symposium Institute of Life Science 2021 (On-line)
26. Novel arginine methylation switch of ONR1 in tumor regulation
Hyuntae Im, Ji Min Lee (2021-01) (poster), International Symposium Institute of Life Science 2021 (On-line)
25. Methyl-degron of ONR in tumor-autophagy axis
Il-Geun Park, Ji Min Lee (2021-01) (poster), International Symposium Institute of Life Science 2021 (On-line)
24. SCF-FbxlX E3 ubiquitin ligase regulates autophagy through PRMT degradation
Su Chan Park, Ji Min Lee (2021-01) (poster), International Symposium Institute of Life Science 2021 (On-line)
23. Enhancing anti-tumor effects of CD8+ T-cell by cholesterol metabolism in tumor microenvironment
Ji Min Lee (2020-01) (speaker), 2020 KSBMB Winter Workshop (Hongcheon, Korea)
22. Controlling Protein Stability by Post-Translational Modifications in Disease
Ji Min Lee (2019-12) (speaker), Epigenomics Symposium 2019 KSMCB (Hongcheon, Korea)
21. Methyl-degron of ONRα in Tumor-autophagy Axis
Il-Geun Park, Ji Min Lee (2019-12) (poster), Epigenomics Symposium 2019 KSMCB (Hongcheon, Korea)
20. Post-translational Modification of Novel Nuclear Receptor in Cancer
Su Chan Park, Ji Min Lee (2019-12) (poster), Epigenomics Symposium 2019 KSMCB (Hongcheon, Korea)
19. Novel strategy for inducing dual target internalization and methyl-degron dependent degradation in cancer
Il-Geun Park, Su Chan Park, Ji Min Lee (2019-10) (poster), Abcam Epigenetics Conference and 14th Asia Epigenome Meeting (AEM) / 3rd Taipei Epigenetics and Chromatin Meeting (TECM) (Taipei, Taiwan)
18. Post-translational Modification of Novel Nuclear Receptor in Cancer
Su Chan Park, Ji Min Lee (2019-10) (poster), Korean Society for Molecular and Cellular Biology (Seoul, Korea)
17. Methyl-degron of ONRα in Tumor-autophagy Axis
Il-Geun Park, Ji Min Lee (2019-10) (poster), Korean Society for Molecular and Cellular Biology (Seoul, Korea)
16. Unlocking crosstalk of PTM in Disease.
Ji Min Lee (2019-06) (Speaker), Cell Cycle Symposium 2019 KSMCB (Samchoek, Korea)
15. N-terminal Domain Mediated Regulation of ONR Inhibits Invasive Growth in Metastatic Prostate Cancer (Best Poster Award)
Su Chan Park, Il Geun Park, Ji Min Lee (2018-06) (poster), Korean Society for Cell Biology (Daejeon, Korea)
14. Novel Strategy for inducing dual target internalization and methyl-degron dependent receptor degradation in cancer
Ji Min Lee (2018-06) (Speaker), Korean Society for Cell Biology (Daejeon, Korea)
13. Novel Strategy for a Bispecific Antibody: Induction of Dual Target Internalization and Degradation.
Ji Min Lee (2016-11) (Speaker), PEGS Europe (Lisbon, Portugal)
12. USP8 modulates ubiquitination of LRIG1 for Met degradation.
Ji Min Lee, Seung Ja Oh, Jaehyun Choi, Seonhui Shim, Bogyou Kim, and Kyung-Ah Kim (2015-04) (poster), American Association for Cancer Research Conference 2015 (Philadelphia, USA)
11. Synthetic lethal screening reveals FGFR as one of combinatorial targets to overcome resistance to Met-targeted therapy.
Bogyou Kim, Ji Min Lee, and Kyung-Ah Kim (2014-04) (poster), American Association for Cancer Research Conference 2014 (San Diego, USA)
10. Cbl-independent degradation of Met: ways to avoid agonism of bivalent Met targeting antibody
Ji Min Lee, Bogyou Kim, and Kyung-Ah Kim (2013-04) (poster), American Association for Cancer Research Conference 2013 (Washington, USA)
09. EZH2 Methylates RORα to Generate a Methyl Degron Recognized by the DCAF1/DDB1/CUL4 E3 Ubiquitin Ligase Complex.
Kyeongkyu Kim, Ji Min Lee, Jason S. Lee, Hyunkyung Kim and Sung Hee Baek (2013-01) (poster), Keystone Symposia, Adipose Tissue Biology (Colorado, USA)
08. Molecular Basis for the Recognition of a Methyl Degron by the DCAF1/DDB1/CUL4 E3 Ubiquitin Ligase Complex.
Hyunkyung Kim, Ji Min Lee, Jason S. Lee, Kyeongkyu Kim, and Sung Hee Baek (2012-06) (poster), The 12th Asian Conference on Transcription (Jeju Island, Korea)
07. Molecular Basis for the Recognition of a Methyl Degron by E3 Ubiquitin Ligase Complex.
Sung Hee Baek, Ji Min Lee, and Keun Il Kim (2011-12) (speaker), Chromatin: Structure & Function 2011, Abcam (Palm Beach, Aruba)
06. Lysine Methylation-dependent Ubiquitination of Orphan Nuclear Receptor.
Ik Soo Kim, Ji Min Lee, Keun Il Kim, and Sung Hee Baek (2010-5) (poster), COLD SPRING HARBOR ASIA CONFERENCES-Epigenetics, Chromatin & Transcription (Suzhou, China)
05. DNA Damage Signal-dependent Induction of Orphan Nuclear Receptor Is Important for p53 Function.
Hyunkyung Kim, Ji Min Lee, Keun Il Kim, and Sung Hee Baek (2010-4) (poster), COLD SPRING HARBOR ASIA CONFERENCES-James Watson Symposium on Cancer (Suzhou, China)
04. Orphan Nuclear Receptor Attenuates Wnt/b-Catenin Signaling by Phosphorylation in Colon Cancer.
Ji Min Lee and Sung Hee Baek (2009-11) (poster), 2009 Chromatin Structure & Function (Guanacaste, Costa Rica)
03. Molecular Determinants of Crosstalk between the Orphan Nuclear Receptors and Wnt/beta-Catenin Signaling Pathways.
Ji Min Lee and Sung Hee Baek (2008-03) (poster), Gordon conference (Il Ciocco, Italy)
02. Crosstalk between Orphan Nuclear Receptors and Wnt Signaling Pathway in Cancer.
Ji Min Lee and Sung Hee Baek (2007-08) (poster), Gordon conference (Les Diablerets, Switzerland)
01. Roles of Nuclear Receptor Coregulators and their modification codes in Regulation of a Metastasis Suppressor Gene.
Ji Min Lee, Ik Soo Kim and Sung Hee Baek (2006-03) (poster), Keystone Symposia (Banff, Canada)